Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.69 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HTR1D | P28221 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | RXRB | P28702 | 5/20 | 0.42 |
| ▸ | RXRA | P19793 | 4/20 | 0.42 |
| ▸ | RXRG | P48443 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HTR1B | P28222 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10394690 | 0.96 | GABRA1 (0.65) | GABRA1GABRB2POLBMAPTGAA | |
| SCHEMBL10415675 | 0.96 | GABRA1 (0.65) | GABRA1GABRB2POLBMAPTGAA | |
| SCHEMBL4572745 | 0.89 | GABRA1 (0.58) | GABRA1GABRB2POLBMAPTGAA | |
| Formaldehyde SCHEMBL22558111 | 0.89 | GABRA1 (0.58) | GABRA1GABRB2POLBMAPTGAA | |
| SCHEMBL26230931 | 0.86 | GABRA1 (0.55) | GABRA1GABRB2POLBMAPTGAA | |
| SCHEMBL10540685 | 0.86 | GABRA1 (0.55) | GABRA1GABRB2POLBMAPTGAA | |
| SCHEMBL1655430 | 0.86 | GABRA1 (0.55) | GABRA1GABRB2POLBMAPTGAA | |
| SCHEMBL25485527 | 0.83 | GABRA1 (0.60) | GABRA1GABRB2POLBMAPTGAA | |
| SCHEMBL7763323 | 0.83 | GABRA1 (0.52) | GABRA1GABRB2POLBMAPTGAA | |
| SCHEMBL22861023 | 0.83 | GABRB2 (0.52) | GABRA1GABRB2POLBMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 426 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444696-B1 | PRODUCTION PROCESS FOR 3,5-DI-TERT-BUTYLBENZENESULFONIC ACID | CHEMOURS CO FC LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250251662-A1 | RADICAL SCAVENGER ADDITIVES FOR METAL OXIDE BASED RESISTS AND PRECURSOR SOLUTIONS | JSR CORPORATION (JP) | 2025-08-07 | — | — | US | claimed |
| US-20250034086-A1 | PRODUCTION PROCESS FOR 3,5-DI-TERT-UTYLBENZENESULFONIC ACID | THE CHEMOURS COMPANY FC, LLC (US) | 2025-01-30 | — | — | US | claimed |
| CN-119330805-A | Preparation method of 3, 5-di-tert-butyl benzyl alcohol | 宁夏忠同生物科技有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119335111-A | Mineral oil automatic detection method, equipment and medium based on secondary difference quotient filtration | 北京市科学技术研究院分析测试研究所(北京市理化分析测试中心) | 2025-01-21 | — | — | CN | claimed |
| CN-115078560-B | Qualitative detection method for mineral oil in wine or beverage | 中国食品发酵工业研究院有限公司 | 2024-08-06 | — | — | CN | claimed |
| US-20240230571-A1 | VOLATILE COMPOUND SOURCE LOCATING SYSTEMS | US DEPARTMENT OF ENERGY | 2024-07-11 | — | — | US | claimed |
| CN-118302408-A | Production method for 3, 5-di-tert-butylbenzene sulfonic acid | 科慕埃弗西有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-115078560-A | Qualitative detection method for mineral oil in wine or beverage | 中国食品发酵工业研究院有限公司 | 2022-09-20 | — | — | CN | claimed |
| US-20220087947-A1 | NANOPARTICLE FOR DELIVERING RIBONUCLEOPROTEIN AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-03-24 | — | — | US | claimed |
| US-8394541-B2 | Lithium secondary battery and non-aqueous electrolytic solution | UBE INDUSTRIES, LTD. (JP) | 2013-03-12 | — | — | US | claimed |
| US-20110250504-A1 | LITHIUM SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTIC SOLUTION | UBE INDUSTRIES, LTD. (JP) | 2011-10-13 | — | — | US | claimed |
| US-6503662-B1 | Tert-butylbenzene derivative prevents oxidation and decomposition of solvent at the time of charging which causes decreased battery characteristics | UBE INDUSTRIES, LTD. (JP) | 2003-01-07 | — | — | US | claimed |
| EP-0781355-B1 | EPITAXIALLY LAYERED STRUCTURE | IBM (US) | 2001-09-19 | — | — | EP | claimed |
| EP-0579658-B1 | OLEFIN POLYMERISATION | BASF AG (DE) | 1996-08-28 | — | — | EP | claimed |
| US-5478901-A | Supported catalyst containing complex of lanthanide metal(s) with alkyl-substituted benzene or fused aromatic rings | BASF AKTIENGESELLSCHAFT (DE) | 1995-12-26 | — | — | US | claimed |
| EP-0579658-A1 | OLEFIN POLYMERISATION. | ICI PLC (GB) | 1994-01-26 | — | — | EP | claimed |
| US-5220086-A | Dealkylation of hydrocarbons | MOBIL OIL CORPORATION (US) | 1993-06-15 | — | — | US | claimed |
| WO-1992017510-A1 | OLEFIN POLYMERISATION | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-10-15 | — | — | WO | claimed |
| US-4973498-A | Volatile lanthanum complexes for use in chemical vapor deposition | THE BRITISH PETROLEUM COMPANY P.L.C. (GB) | 1990-11-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250251662-A1 | RADICAL SCAVENGER ADDITIVES FOR METAL OXIDE BASED RESISTS AND PRECURSOR SOLUTIONS | SOD1, SOD3, MGMT | GABRA1 4421/4885GABRB2 4084/4885POLB 106/4885 |
| US-20250034086-A1 | PRODUCTION PROCESS FOR 3,5-DI-TERT-UTYLBENZENESULFONIC ACID | TST, TERT, UTS2R | GABRA1 819/4885GABRB2 729/4885POLB 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.